Literature DB >> 28857074

Breast cancer: AKT inhibition effective against TNBC.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28857074     DOI： 10.1038/nrclinonc.2017.147

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Sung-Bae Kim; Rebecca Dent; Seock-Ah Im; Marc Espié; Sibel Blau; Antoinette R Tan; Steven J Isakoff; Mafalda Oliveira; Cristina Saura; Matthew J Wongchenko; Amy V Kapp; Wai Y Chan; Stina M Singel; Daniel J Maslyar; José Baselga
Journal:  Lancet Oncol       Date:  2017-08-08       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.